Samuel L Díaz-Muñoz

11PUBLICATIONS
133CO-AUTHORS
Medical virologyMajor global burdens of diseaseAnimal protection (incl. pests and pathogens)Molecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 19, 2025
Host PI3K inhibition via anti-cancer drug alpelisib influences Influenza A non-infectious particles and deletion-containing viral genomes.

Ilechukwu Agu, Ivy José, Abhineet Ram

|Sep 29, 2025
Host cell state: an overlooked factor impacting the production of influenza A deletion-containing viral genomes and non-infectious particles.

Ilechukwu Agu, Samuel L Díaz-Muñoz

|Apr 30, 2025
Mitigating Risk: Predicting H5N1 Avian Influenza Spread with an Empirical Model of Bird Movement.

Fiona McDuie, Cory T Overton, Austen A Lorenz

|Jul 15, 2024
Influenza A defective viral genomes and non-infectious particles are increased by host PI3K inhibition via anti-cancer drug alpelisib.

Ilechukwu Agu, Ivy José, Abhineet Ram

|Jul 15, 2024
Influenza A defective viral genome production is altered by metabolites, metabolic signaling molecules, and cyanobacteria extracts.

Ilechukwu Agu, Ivy R José, Samuel L Díaz-Muñoz

|Mar 01, 2023
Influenza A virus reassortment is strain dependent.

Kishana Y Taylor, Ilechukwu Agu, Ivy José

Pageof 2

Frequent Collaborators

2 joint publications

Marlee A Tucker

2 joint publications

Claudia Fichtel

2 joint publications

Nina Attias

2 joint publications

Benedikt Gehr